Literature DB >> 35359226

Tau Toxicity in Neurodegeneration.

Shu-Yu Liang1, Zuo-Teng Wang2, Lan Tan3,4, Jin-Tai Yu5.   

Abstract

Tau is a microtubule-associated protein widely distributed in the central nervous system (CNS). The main function of tau is to promote the assembly of microtubules and stabilize their structure. After a long period of research on neurodegenerative diseases, the function and dysfunction of the microtubule-associated protein tau in neurodegenerative diseases and tau neurotoxicity have attracted increasing attention. Tauopathies are a series of progressive neurodegenerative diseases caused by pathological changes in tau, such as abnormal phosphorylation. The pathological features of tauopathies are the deposition of abnormally phosphorylated tau proteins and the aggregation of tau proteins in neurons. This article first describes the normal physiological function and dysfunction of tau proteins and then discusses the enzymes and proteins involved in tau phosphorylation and dephosphorylation, the role of tau in cell dysfunction, and the relationships between tau and several neurodegenerative diseases. The study of tau neurotoxicity provides new directions for the treatment of tauopathies.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Alzheimer’s disease; Neurodegenerative disease; Tau protein; Toxicity

Mesh:

Substances:

Year:  2022        PMID: 35359226     DOI: 10.1007/s12035-022-02809-3

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.682


  129 in total

1.  Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation.

Authors:  Zhuohao He; Jing L Guo; Jennifer D McBride; Sneha Narasimhan; Hyesung Kim; Lakshmi Changolkar; Bin Zhang; Ronald J Gathagan; Cuiyong Yue; Christopher Dengler; Anna Stieber; Magdalena Nitla; Douglas A Coulter; Ted Abel; Kurt R Brunden; John Q Trojanowski; Virginia M-Y Lee
Journal:  Nat Med       Date:  2017-12-04       Impact factor: 53.440

2.  The Binding Mode of a Tau Peptide with Tubulin.

Authors:  Harindranath Kadavath; Yunior Cabrales Fontela; Mariusz Jaremko; Łukasz Jaremko; Kerstin Overkamp; Jacek Biernat; Eckhard Mandelkow; Markus Zweckstetter
Journal:  Angew Chem Int Ed Engl       Date:  2018-02-22       Impact factor: 15.336

Review 3.  The Accumulation of Tau in Postsynaptic Structures: A Common Feature in Multiple Neurodegenerative Diseases?

Authors:  Peter J Teravskis; Karen H Ashe; Dezhi Liao
Journal:  Neuroscientist       Date:  2020-05-09       Impact factor: 7.519

Review 4.  Tau in physiology and pathology.

Authors:  Yipeng Wang; Eckhard Mandelkow
Journal:  Nat Rev Neurosci       Date:  2015-12-03       Impact factor: 34.870

5.  Isoform-independent and -dependent phosphorylation of microtubule-associated protein tau in mouse brain during postnatal development.

Authors:  Dilina Tuerde; Taeko Kimura; Tomohiro Miyasaka; Kotaro Furusawa; Aki Shimozawa; Masato Hasegawa; Kanae Ando; Shin-Ichi Hisanaga
Journal:  J Biol Chem       Date:  2017-12-01       Impact factor: 5.157

6.  Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization.

Authors:  M Goedert; R Jakes
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

7.  Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice.

Authors:  Jing L Guo; Sneha Narasimhan; Lakshmi Changolkar; Zhuohao He; Anna Stieber; Bin Zhang; Ronald J Gathagan; Michiyo Iba; Jennifer D McBride; John Q Trojanowski; Virginia M Y Lee
Journal:  J Exp Med       Date:  2016-10-17       Impact factor: 14.307

8.  Microtubules gate tau condensation to spatially regulate microtubule functions.

Authors:  Ruensern Tan; Aileen J Lam; Tracy Tan; Jisoo Han; Dan W Nowakowski; Michael Vershinin; Sergi Simó; Kassandra M Ori-McKenney; Richard J McKenney
Journal:  Nat Cell Biol       Date:  2019-09-02       Impact factor: 28.824

9.  In vitro amplification of pathogenic tau conserves disease-specific bioactive characteristics.

Authors:  Hong Xu; Mia O'Reilly; Garrett S Gibbons; Lakshmi Changolkar; Jennifer D McBride; Dawn M Riddle; Bin Zhang; Anna Stieber; Jeffrey Nirschl; Soo-Jung Kim; Kevt-Her Hoxha; Kurt R Brunden; Gerard D Schellenberg; John Q Trojanowski; Virginia M-Y Lee
Journal:  Acta Neuropathol       Date:  2021-01-01       Impact factor: 17.088

10.  Tau deposition is associated with functional isolation of the hippocampus in aging.

Authors:  Theresa M Harrison; Anne Maass; Jenna N Adams; Richard Du; Suzanne L Baker; William J Jagust
Journal:  Nat Commun       Date:  2019-10-25       Impact factor: 14.919

View more
  1 in total

Review 1.  Applications and challenges of rhodopsin-based optogenetics in biomedicine.

Authors:  Hanci Zhang; Hui Fang; Deqiang Liu; Yiming Zhang; Joseph Adu-Amankwaah; Jinxiang Yuan; Rubin Tan; Jianping Zhu
Journal:  Front Neurosci       Date:  2022-09-23       Impact factor: 5.152

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.